Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Equity Average (2020 - 2025)

Historic Equity Average for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $19.0 million.

  • NeuroPace's Equity Average rose 9259.18% to $19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.0 million, marking a year-over-year increase of 9259.18%. This contributed to the annual value of $14.3 million for FY2024, which is 4828.35% down from last year.
  • As of Q3 2025, NeuroPace's Equity Average stood at $19.0 million, which was up 9259.18% from $21.9 million recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Equity Average ranged from a high of $85.2 million in Q3 2021 and a low of -$152.1 million during Q1 2021
  • In the last 5 years, NeuroPace's Equity Average had a median value of $19.0 million in 2025 and averaged $20.4 million.
  • Per our database at Business Quant, NeuroPace's Equity Average skyrocketed by 27076.14% in 2022 and then plummeted by 6097.12% in 2023.
  • Over the past 5 years, NeuroPace's Equity Average (Quarter) stood at $77.6 million in 2021, then tumbled by 49.63% to $39.1 million in 2022, then plummeted by 52.66% to $18.5 million in 2023, then crashed by 51.82% to $8.9 million in 2024, then surged by 112.81% to $19.0 million in 2025.
  • Its Equity Average stands at $19.0 million for Q3 2025, versus $21.9 million for Q2 2025 and $16.1 million for Q1 2025.